There are 1105 resources available
416P - A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with chemotherapy for the treatment of anti-PD-1 resistant, recurrent, or metastatic nasopharyngeal carcinoma (R/M NPC)
Presenter: Lu Wen
Session: Poster Display session
Resources:
Abstract
417P - Final and exploratory results of a phase I trial evaluating novel radioenhancer NBTXR3 activated by radiotherapy in cisplatin-ineligible LA HNSCC patients
Presenter: Christophe Le Tourneau
Session: Poster Display session
Resources:
Abstract
418P - Updated results of toripalimab combined with cetuximab in PD-L1 positive untreated recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase Ib/II study
Presenter: Ye Guo
Session: Poster Display session
Resources:
Abstract
419P - Escalated dose PAINTing IntEnsity modulated Radiotherapy (PAINTER) for inoperable locally advanced head and neck squamous cell carcinoma (LAHNSCC)
Presenter: Umesh Velu
Session: Poster Display session
Resources:
Abstract
420P - Pretreatment 18F-FDG PET-CT parameters can predict survival in patients with de novo metastatic nasopharyngeal carcinoma receiving chemotherapy combination anti-programmed death-1 immunotherapy
Presenter: Liwen Gu
Session: Poster Display session
Resources:
Abstract
421P - Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)
Presenter: Nobukazu Tanaka
Session: Poster Display session
Resources:
Abstract
422P - Claudin-1 (CLDN1) expression in nasopharyngeal carcinoma (NPC): Association with immune exclusion and implications for immune checkpoint inhibitor (ICI) therapy
Presenter: Eugenia Yeo
Session: Poster Display session
Resources:
Abstract
423P - NF-κB signaling pathway activity leads to identification of novel molecular biomarkers in HPV-associated head and neck cancer
Presenter: Aditi Kothari
Session: Poster Display session
Resources:
Abstract
424P - Prognostic implications of histological bone involvement in oral squamous cell carcinoma: A comparative analysis
Presenter: Abhinav Thaduri
Session: Poster Display session
Resources:
Abstract
425P - 18F-FAPI PET/CT imaging to explore the evaluation of immunotherapy efficacy in HNSCC
Presenter: Na Li
Session: Poster Display session
Resources:
Abstract